ENGLISH 繁體中文 ENGLISH About Visco Vision Vision & Mission Introduction Milestone Business Overview Investors Corporate Governance Financial Information Shareholders CSR Social Responsibilities Stakeholders Risk Management Green Operation Contact…

ENGLISH
繁體中文
ENGLISH
About Visco Vision
Vision & Mission
Introduction
Milestone
Business Overview
Investors
Corporate Governance
Financial Information
Shareholders
CSR
Social Responsibilities
Stakeholders
Risk Management
Green Operation
Contact
Language
繁體中文
ENGLISH

Investors-Financial Information
Material Information
Home
Investors
Financial Information
Material Information
Material Information Announcement
Click on the Market Observation Post System
for public information, where you can search for significant information by year/month. Please enter the code 6782 for Visco Vision Inc. on the page linked.
SEQ_NO 10
Date of announcement 2026/05/26
Time of announcement 15:22:47
To which item it meets paragraph 6
Date of events 2026/05/26
Subject To announce the re-election of all Directors (including Independent Directors)in the 2026 Annual Shareholders' Meeting.
Statement
- Date of occurrence of the change:2026/05/26
- Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor):natural-person director、institutional director、independent director
- Title and name of the previous position holder:
Director:
(1)Chung-I Li
(2)BenQ Materials Corp. representative:Pei-I Liu
(3)Ke-Yung Yu
(4)Sheng-Wen Chen
Independent Director:
(1)Chiu-Jui Wei
(2)Ying-Chou Yang
(3)Kuo-Kuang Chao
(4)Wei-Ting Lai
- Resume of the previous position holder:
Director:
(1)Chung-I Li
Chairperson of Visco Vision Inc.
Corporate Chairperson Representative and CSO, Crystalvue Medical Corp.
Corporate Chairperson Representative, Trend Young Vision Care Inc.
(2)BenQ Materials Corp. representative:Pei-I Liu
Vice President of BenQ Materials Corp.
CTO, BenQ Materials Corp.
(3)Ke-Yung Yu
Chairperson, BenQ Materials Corp.
Director, AUO Corp.
Deputy General Manager of Finance, Qisda Corp.
(4)Sheng-Wen Chen
Business Division, BenQ Corporation
Director of R&D, Qualcomm Inc.
Independent Director:
(1)Chiu-Jui Wei
Senior Vice President of Compal Electronics Inc.
Independent Director, Continental Holdings Corp
CFO and Senior Vice President, Toppoly Optoelectronics Corp.
(2)Ying-Chou Yang
Independent Director, TSRC Corporation
Chairperson, Kaimei Electronic Corp.
CFO/CSO, YAGEO Corporation
(3)Kuo-Kuang Chao
Acting Executive Director, Nano-Optoelectromagnetics Research Center of NTUT
Chairperson, OU JIE TECHNOLOGY CO., LTD.
Vice President, Posiflex Technology Inc.
(4)Wei-Ting Lai
Director of Ophthalmology, Min-Sheng General Hospital
CMO, EyePlus
CEO, EyePlus Co., Ltd.
- Title and name of the new position holder:
Director:
(1)Chung-I Li
(2)BenQ Materials Corp. representative:Pei-I Liu
(3)Ke-Yung Yu
(4)Sheng-Wen Chen
Independent Director:
(1)Chiu-Jui Wei
(2)Ying-Chou Yang
(3)Kuo-Kuang Chao
(4)Wei-Ting Lai
(5)Chi-Chang Chen
- Resume of the new position holder:
Director:
(1)Chung-I Li
Chairperson of Visco Vision Inc.
Corporate Chairperson Representative and CSO, Crystalvue Medical Corp.
Corporate Chairperson Representative, Trend Young Vision Care Inc.
(2)BenQ Materials Corp. representative:Pei-I Liu
Vice President of BenQ Materials Corp.
CTO, BenQ Materials Corp.
(3)Ke-Yung Yu
Chairperson, BenQ Materials Corp.
Director, AUO Corp.
Deputy General Manager of Finance, Qisda Corp.
(4)Sheng-Wen Chen
Business Division, BenQ Corporation
Director of R&D, Qualcomm Inc.
Independent Director:
(1)Chiu-Jui Wei
Senior Vice President of Compal Electronics Inc.
Independent Director, Continental Holdings Corp
CFO and Senior Vice President, Toppoly Optoelectronics Corp.
(2)Ying-Chou Yang
Independent Director, TSRC Corporation
Chairperson, Kaimei Electronic Corp.
CFO/CSO, YAGEO Corporation
(3)Kuo-Kuang Chao
Acting Executive Director, Nano-Optoelectromagnetics Research Center of NTUT
Chairperson, OU JIE TECHNOLOGY CO., LTD.
Vice President, Posiflex Technology Inc.
(4)Wei-Ting Lai
Director of Ophthalmology, Min-Sheng General Hospital
CMO, EyePlus
CEO, EyePlus Co., Ltd.
(5)Chi-Chang Chen
President, Yuanta Venture Capital Co., Ltd.
CEO, Director, Overseas Subsidiary Director, Yuanta Securities Co., Ltd.
- Circumstances of change (Please enter “resignation”, “dismissal”,“term expired”, “death” or “new appointment”):term expired
- Reason for the change:term expired
- Number of shares held by the new position holder when elected:
Director:
(1)Chung-I Li 211,625 Shares
(2)BenQ Materials Corp. 9,333,773 Shares
(3)Ke-Yung Yu 779,036 Shares
(4)Sheng-Wen Chen 100,000 Shares
Representative:Pei-I Liu 380,683 Shares
Independent Director:
(1)Chiu-Jui Wei 0 Shares
(2)Ying-Chou Yang 0 Shares
(3)Kuo-Kuang Chao 0 Shares
(4)Wei-Ting Lai 66,517 Shares
(5)Chi-Chang Chen 0 Shares
- Original term (from __________ to __________):2023/05/30~2026/05/29
- Effective date of the new appointment:2026/05/26
- Turnover rate of directors of the same term:N/A
- Turnover rate of independent directors of the same term:N/A
- Turnover rate of supervisors of the same term:N/A
- Change in one-third or more of directors (Please enter “Yes” or “No”):No
- Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 6 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):N/A
Go Back

About Visco Vision
Business Overview
Products
Quality
Investors
CSR
Address
No. 1, Xingye St., Guishan Dist., Taoyuan City 33341, Taiwan
Phone
+886-3-359-6868
Fax
+886-3-349-0202
E-mail
[email protected]
© Copyright by VISCO VISION INC. All Rights Reserved.
